iHuman (IH) Fundamental Analysis: Revenue, Earnings & Valuation

0.42 / 10

Underperform

Fundamental assessment rates IH as underperform (0.4/10). Asset‑MV and cash‑up show modest positives, but current liabilities dominate total liabilities (97.5%) and non‑current liabilities are low, indicating balance‑sheet strain. Interest coverage is adequate (15.6×) while ROA and asset returns are negative.

Analysis Checks(4/10)

ROA (%)

Value5.74

Score1/3

Weight6.57%

1M Return-0.47%

Current liabilities / Total liabilities (%)

Value97.50

Score0/3

Weight42.24%

1M Return-3.88%

Profit-MV

Value2.93

Score2/3

Weight-7.97%

1M Return0.58%

Non-current liabilities / Total liabilities (%)

Value2.50

Score0/3

Weight37.83%

1M Return-3.52%

Rate of return on total assets (%)

Value-12.69

Score0/3

Weight52.43%

1M Return-5.26%

Cash-UP

Value-0.01

Score2/3

Weight39.88%

1M Return-4.22%

Annualized return on total assets (%)

Value-16.92

Score0/3

Weight52.43%

1M Return-5.26%

Annualized net profit margin on total assets (%)

Value7.65

Score1/3

Weight6.57%

1M Return-0.47%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.64

Score2/3

Weight-7.08%

1M Return0.54%

Asset-MV

Value-0.49

Score2/3

Weight-122.91%

1M Return7.50%

Is IH undervalued or overvalued?

IH scores 0.42/10 on fundamentals and holds a Premium valuation at present. Backed by its 9.75% ROE, 11.82% net margin, 6.07 P/E ratio, 0.58 P/B ratio, and 3.27% earnings growth, these metrics solidify its Underperform investment rating.